Kansas City Celebrates UMKC Carnegie R1 Status at Union Station
Community leaders came together to celebrate impact research milestone will have for region
Kansas City Skyline with Union Station in Forefront
Kansas City Community Leaders Celebrate
Kansas City, MO, June 18, 2025 (GLOBE NEWSWIRE) -- Federal, state, county, city, business and university leaders gathered at Union Station to celebrate the University of Missouri-Kansas City's designation as a Carnegie Research 1 university. They spoke about the economic impact of this national designation for the Kansas City community, Missouri and beyond. State Representative Melissa Douglas recognized the university's milestone with a state resolution, and Kansas City Mayor Quinton Lucas recognized it with a city proclamation.
UMKC achieved Carnegie Research 1, or R1, designation earlier this year. The designation reflects university-wide dedication to research, innovation and community collaboration. Of all four-year institutions in the United States, only 6% are R1 and UMKC is the only one in Kansas City. The R1 designation elevates the academic prestige of UMKC, providing more opportunities for faculty and students through recruitment and research grants. UMKC researchers demonstrated research at Union Station including drones, nursing simulations and more.
This designation isn't just a milestone for the university; the benefits will echo through the community and beyond. Prestigious faculty and research grants will bring new jobs and opportunities into the region. The research happening at UMKC makes an impact of more than $300 million to the greater Kansas City area each year. Additionally, the university's research activity annually brings an estimated 2,000 jobs to the area.
Leaders expressed excitement about what this means for our region:
Charlie Shields, chair of Greater Kansas City Chamber of Commerce, president and CEO of University Health and UMKC Trustee: 'UMKC research advances our safety as a society and our health and wellbeing – impacts I see every day at University Health. UMKC is leading the way in key areas of research, including electromagnetic radiation and energy, advanced and critical materials, unmanned platforms, cybersecurity and digital humanities.'
U.S. Representative Mark Alford: 'What UMKC is doing in the defense and security space has already led to the creation of private businesses and jobs and has massive potential for continued growth. This milestone only further helps expand on what could have a massive economic impact on the Midwest, creating business and jobs in the region that help our country receive the materials it needs from areas in Kansas and Missouri.'
State Representative Melissa Douglas: 'I see UMKC serving in healthcare throughout the state of Missouri, not only at its Health Sciences Campus in Kansas City, but through its satellite campuses to serve rural Missourians. As UMKC continues to expand its healthcare outreach throughout the state of Missouri, I know we'll see more needed research to improve the lives of all Missourians. Together, we have built a hub of intellectual vitality that will have benefits for years to come.'
Kansas City Mayor Quinton Lucas: 'I'm quite familiar with the good works at UMKC, and grew up with it, as my mother worked there. I've seen the city and the university grow together to become world class, and this important R1 designation is a testament to that.'
Jackson County Executive Frank White: 'I've seen up close how UMKC research can help communities. Our Healthy Jackson County truly made a difference to so many people's lives. And UMKC's community-participatory research truly makes a difference to so many people's lives.'
UMKC Student Government Association President Justice Horn: 'This isn't just a title. It's a transformation. For students, it means expanded opportunities, greater visibility and stronger preparation for our futures. It's a game changer—and a sign that UMKC is investing in discovery, innovation and real-world impact right here in the Kansas City community.'
UMKC Chancellor Mauli Agrawal: 'This moment reflects the work of an entire community that believes in the power of education, research and partnership to shape a better future for all of us. And it reflects a university that has long been deeply embedded in the life of this city – from healthcare and entrepreneurship to science, the arts and urban development.'
Tim Cowden, President and CEO of the Kansas City Area Development Council: 'This R1 status helps elevate our brand to the world. Kansas City's status is rising. The R1 designation is a welcome mat to talent not just in the Kansas City area, but around the world.'
Celebrations continued as buildings around the city lit up in recognition of the university's Carnegie Research 1 status. Union Station, Children's Mercy, Saint Luke's Hospital, Country Club Plaza, City Hall, KC Wheel and Power and Light Building were illuminated UMKC blue and gold.
Read more about UMKC's Carnegie R1 impact, including a roundtable discussion among two dozen regional leaders, at go.umkc.edu/r1.
Attachments
Kansas City Skyline with Union Station in Forefront
Kansas City Community Leaders Celebrate
CONTACT: Stacy Downs UMKC 8162351441 downs@umkc.eduSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
5 hours ago
- Business Upturn
OGN FRAUD ALERT: Organon & Co. Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 22 Legal Deadline (NYSE:OGN)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting Investors have until July 22, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Organon securities. The case is pending in the U.S. District Court for the District of New Jersey and is captioned: Hauser v. Organon & Co., et al. , No. 25-cv-05322. Why was Organon Sued for Securities Fraud? Organon is a global healthcare company focused on women's health that has historically rewarded its shareholders with a healthy dividend. In October 2024, Organon completed a $1.2 billion acquisition of Dermavant, a biopharmaceutical company focused on dermatological conditions. As alleged, while the acquisition increased Organon's debt, the Company assured investors it would maintain its dividend, which Organon asserted was its '#1 capital allocation priority.' In truth, Organon had shifted its capital allocation priority after the Dermavant acquisition to focus on reducing its debt, ultimately leading the Company to severely cut its dividend. The Stock Declines as the Truth is Revealed On May 1, 2025, Organon announced that management reset the Company's dividend payout from $0.28 per share to $0.02 per share. Organon's CEO explained that the Company 'reset our capital allocation priorities to accelerate progress towards deleveraging' and that '[b]y deleveraging more rapidly, we will continue to strengthen the future prospects of the company.' Organon's CFO added, '[t]he biggest issues we face . . . relate to managing our leverage and relate to growth. And we need capital to solve both of those issues, and so returning capital to shareholders is right now, less of a priority.' On this news, the price of Organon stock declined roughly 27%, from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025. Click here if you suffered losses: What Can You Do? If you invested in Organon you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
5 hours ago
- Business Upturn
IOVA FRAUD ALERT: Iovance Biotherapeutics Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
5 hours ago
- Business Upturn
AIXA Miner Integrates AI and Clean Energy to Power a New Era of Cloud Mining in 2025
Denver, CO, USA, June 22, 2025 (GLOBE NEWSWIRE) — In a major advancement for the global crypto mining industry, AIXA Miner today announced the expansion of its AI-powered cloud mining platform, now fully supported by green energy sources. The move strengthens AIXA Miner's position as a forward-thinking player in the digital asset space, while making daily crypto income more accessible and more sustainable for users worldwide. As interest in decentralized finance grows and regulatory focus sharpens, 2025 is proving to be a pivotal year for crypto mining. AIXA Miner's cloud-based system offers a hardware-free, AI-optimized, and environmentally conscious mining solution that requires no prior technical knowledge or large capital investment. Bridging Crypto, AI, and Sustainability Designed for beginners and experienced users alike, AIXA Miner enables anyone to start earning daily rewards in leading cryptocurrencies — including Bitcoin, Ethereum, and Litecoin — through its intelligent, cloud-hosted mining architecture. The platform's unique value lies in its combination of: Artificial intelligence , used to dynamically allocate mining resources for optimal output , used to dynamically allocate mining resources for optimal output Clean energy-powered mining farms , cutting environmental impact , cutting environmental impact Free sign-up mining trial , giving newcomers a risk-free entry point , giving newcomers a risk-free entry point Low-cost mining contracts , with flexible durations and terms , with flexible durations and terms Daily payouts and full earnings control, accessible via a secure user dashboard In line with the industry's green transition, AIXA's energy-efficient infrastructure operates in regions with abundant renewable energy sources, aligning with broader ESG standards and carbon neutrality goals. Making Daily Crypto Income Simple AIXA Miner's goal is to eliminate complexity from crypto mining. Users simply register with an email, choose a mining plan (or start with the free trial), and the platform's backend takes care of everything — from resource allocation to performance tracking. With 24/7 cloud uptime, earnings accumulate automatically, and users can withdraw or reinvest anytime. This 'plug-and-earn' experience reflects a growing demand for low-risk, passive income solutions that don't rely on expensive hardware or volatile trading environments. Start Mining in Minutes Go to Register with your email to activate your free trial Choose the crypto you want to mine Let the AI-powered engine begin mining Monitor your earnings in real-time Withdraw anytime, or grow your income with longer-term plans Building a Smarter Mining Future AIXA Miner's 2025 expansion is not just about mining more coins — it's about doing so responsibly, intelligently, and inclusively. With built-in support for multiple global languages and secure wallet integrations, the platform is tailored for a worldwide user base seeking transparent, stable, and eco-friendly mining solutions. About AIXA Miner Founded in 2020, AIXA Miner is a U.S.-based cloud mining platform powered by renewable energy and artificial intelligence. With a presence in over 200 countries and regulatory certifications, the platform delivers secure, daily-yield mining services that are easy to access and designed for long-term sustainability. For more information, visit: [ Disclaimer: The information provided in this press release does not constitute an investment solicitation, nor does it constitute investment advice, financial advice, or trading recommendations. Cryptocurrency mining and staking involve risks and the possibility of losing funds. It is strongly recommended that you perform due diligence before investing or trading in cryptocurrencies and securities, including consulting a professional financial advisor. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
